NASDAQ: BIOA
Bioage Labs Inc Stock Ownership - Who owns Bioage Labs?

Insider buying vs selling

Have Bioage Labs Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul D. RubinChief Medical Officer2025-12-0918,000$6.57
$118.26kBuy
Paul D. RubinChief Medical Officer2025-12-0918,000$12.00
$216.00kSell
Paul D. RubinChief Medical Officer2025-12-0468,897$4.11
$283.17kBuy
Paul D. RubinChief Medical Officer2025-12-0468,897$10.19
$701.92kSell

1 of 1

BIOA insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BIOA insiders and whales buy or sell their stock.

BIOA Shareholders

What type of owners hold Bioage Labs Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vijay Satyanand Pande9.02%3,233,170$41.22MInsider
A16z Capital Management LLC9.02%3,233,170$41.22MInstitution
James Healy6.43%2,304,901$29.39MInsider
Sofinnova Investments Inc6.40%2,293,788$29.25MInstitution
Cormorant Asset Management LP5.97%2,140,605$27.29MInstitution
Adar1 Capital Management LLC5.24%1,880,073$23.97MInstitution
Patrick G. Enright4.77%1,710,589$21.81MInsider
Vanguard Group Inc4.61%1,651,247$21.05MInstitution
Cormorant Asset Management LP4.54%1,629,529$20.78MInsider
Tang Capital Management LLC4.46%1,600,000$20.40MInstitution

1 of 3

BIOA vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIOA59.29%24.78%Net BuyingNet Buying
SIGA35.34%64.66%Net Selling
EOLS75.33%24.67%Net Selling
ETON65.90%33.34%Net SellingNet Selling
KMDA10.37%0.00%

Bioage Labs Stock Ownership FAQ

Who owns Bioage Labs?

Bioage Labs (NASDAQ: BIOA) is owned by 59.29% institutional shareholders, 24.78% Bioage Labs insiders, and 15.93% retail investors. Vijay Satyanand Pande is the largest individual Bioage Labs shareholder, owning 3.23M shares representing 9.02% of the company. Vijay Satyanand Pande's Bioage Labs shares are currently valued at $41.64M.

If you're new to stock investing, here's how to buy Bioage Labs stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.